PD patients also exhibit reduced GCase activity in different tissues, including the brain (Gegg et al., 2012), regardless of their GBA1 mutation status (Gegg et al., 2012; Parnetti et al., 2017; Atashrazm et al., 2018). This evidence concerns the gene GBA1 and Parkinson disease.